101 related articles for article (PubMed ID: 18787507)
1. Pharmacological effects of lipid-lowering drugs recapitulate with a larger amplitude the phenotypic effects of common variants within their target genes.
Knouff CW; Lim N; Song K; Yuan X; Walker MC; Townsend R; Waeber G; Matthews PM; Vollenweider P; Waterworth DM; Mooser V
Pharmacogenet Genomics; 2008 Dec; 18(12):1051-7. PubMed ID: 18787507
[TBL] [Abstract][Full Text] [Related]
2. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.
Winkelmann BR; Hoffmann MM; Nauck M; Kumar AM; Nandabalan K; Judson RS; Boehm BO; Tall AR; Ruaño G; März W
Pharmacogenomics J; 2003; 3(5):284-96. PubMed ID: 14583798
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Langmann T
Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
[TBL] [Abstract][Full Text] [Related]
5. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
[TBL] [Abstract][Full Text] [Related]
6. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.
Vergeer M; Bots ML; van Leuven SI; Basart DC; Sijbrands EJ; Evans GW; Grobbee DE; Visseren FL; Stalenhoef AF; Stroes ES; Kastelein JJ
Circulation; 2008 Dec; 118(24):2515-22. PubMed ID: 19029469
[TBL] [Abstract][Full Text] [Related]
7. beta2 adrenoceptor (ADRB2) pharmacogenetics and cardiovascular phenotypes during laryngoscopy and tracheal intubation.
Kaymak C; Kocabaş NA; Durmaz E; Oztuna D
Int J Toxicol; 2006; 25(6):443-9. PubMed ID: 17132602
[TBL] [Abstract][Full Text] [Related]
8. A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development.
Zhao L; Jin W; Rader D; Packard C; Feuerstein G
Biochem Pharmacol; 2009 Aug; 78(4):315-25. PubMed ID: 19539799
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics: progress, pitfalls and clinical potential for coronary heart disease.
Humphries SE; Hingorani A
Vascul Pharmacol; 2006 Feb; 44(2):119-25. PubMed ID: 16359930
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease.
Folkersen L; van't Hooft F; Chernogubova E; Agardh HE; Hansson GK; Hedin U; Liska J; Syvänen AC; Paulsson-Berne G; Franco-Cereceda A; Hamsten A; Gabrielsen A; Eriksson P;
Circ Cardiovasc Genet; 2010 Aug; 3(4):365-73. PubMed ID: 20562444
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study.
de Keyser CE; Eijgelsheim M; Hofman A; Sijbrands EJ; Maitland-van der Zee AH; van Duijn CM; Uitterlinden AG; Witteman JC; Ch Stricker BH
Pharmacogenomics J; 2011 Feb; 11(1):72-80. PubMed ID: 20195290
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.
Sekigawa T; Tajima A; Hasegawa T; Hasegawa Y; Inoue H; Sano Y; Matsune S; Kurono Y; Inoue I
Clin Exp Allergy; 2009 Jul; 39(7):972-81. PubMed ID: 19489917
[TBL] [Abstract][Full Text] [Related]
13. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study.
Padmanabhan S; Menni C; Lee WK; Laing S; Brambilla P; Sega R; Perego R; Grassi G; Cesana G; Delles C; Mancia G; Dominiczak AF
J Hypertens; 2010 Mar; 28(3):465-77. PubMed ID: 20032787
[TBL] [Abstract][Full Text] [Related]
14. I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population.
Doğru-Abbasoğlu S; Parildar-Karpuzoğlu H; Depboylu B; Cine N; Uysal M; Aykaç-Toker G
Cell Biochem Funct; 2009 Mar; 27(2):76-80. PubMed ID: 19165812
[TBL] [Abstract][Full Text] [Related]
15. Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure.
Blasi E; Bamberger M; Knight D; Engwall M; Wolk R; Winter S; Betts A; John-Baptiste A; Keiser J
J Cardiovasc Pharmacol; 2009 Jun; 53(6):507-16. PubMed ID: 19455053
[TBL] [Abstract][Full Text] [Related]
16. Using genome-wide pathway analysis to unravel the etiology of complex diseases.
Elbers CC; van Eijk KR; Franke L; Mulder F; van der Schouw YT; Wijmenga C; Onland-Moret NC
Genet Epidemiol; 2009 Jul; 33(5):419-31. PubMed ID: 19235186
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on HDL-raising therapies: insights from the torcetrapib trials.
Kontush A; Guérin M; Chapman MJ
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):329-36. PubMed ID: 18431367
[TBL] [Abstract][Full Text] [Related]
18. Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
van den Oord EJ; Kuo PH; Hartmann AM; Webb BT; Möller HJ; Hettema JM; Giegling I; Bukszár J; Rujescu D
Arch Gen Psychiatry; 2008 Sep; 65(9):1062-71. PubMed ID: 18762592
[TBL] [Abstract][Full Text] [Related]
19. TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study.
Xu C; Li PP; Cooke RG; Parikh SV; Wang K; Kennedy JL; Warsh JJ
Bipolar Disord; 2009 Feb; 11(1):1-10. PubMed ID: 19133961
[TBL] [Abstract][Full Text] [Related]
20. Defining the spectrum of alleles that contribute to blood lipid concentrations in humans.
Kathiresan S; Musunuru K; Orho-Melander M
Curr Opin Lipidol; 2008 Apr; 19(2):122-7. PubMed ID: 18388691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
